G. P. Tosolini

Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man

L. M. Fuccella, G Corvi, E. Moro et al. · European Journal of Clinical Pharmacology · 1979 · 27 citations

Thrombopoiesis, Thrombosis, Blood Platelet +9

Indobufen (K 3920), a new inhibitor of platelet aggregation: Effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man

V. Tamassia, G Corvi, L. M. Fuccella et al. · European Journal of Clinical Pharmacology · 1979 · 23 citations

Thrombopoiesis, Molecular Pharmacology, Thrombosis +9

Studies on antiprotozoans—III

P. N. GIRALDI, G. P. Tosolini, E. Dradi et al. · Biochemical Pharmacology · 1971 · 22 citations

Antiparasitic Agent, Medicine, Pharmacology +2

Fate of the analgesic and anti-inflammatory drug K 4277 after oral administration to man

L. M. Fuccella, Giancarlo Goldaniga, E. Moro et al. · European Journal of Clinical Pharmacology · 1973 · 22 citations

Inflammation, Anti-inflammatory, Health Sciences +11

GLC Determination of Plasma Levels of Enantiomers of α-[4-(1-Oxo-2-isoindolinyl)phenyl]propionic Acid

G. P. Tosolini, E. Moro, A. Forgione et al. · Journal of Pharmaceutical Sciences · 1974 · 22 citations

Glc Determination, Biochemistry, Medicine +8